Borosil Limited — Q1 FY27 Earnings Conference Call (held Aug 19, 2026)
1. Overall Tone of Management: Neutral
- Management highlights steady revenue growth (“9% Y-o-Y growth”) and multiple execution wins (Hydra lines commissioned; solar plant commissioned; retail stores launched).
- However, they repeatedly emphasize near-term margin pressure and uncertainty from macro/input shocks (“West Asia conflict”, “Hydra… challenges adversely impacted”).
- Guidance is given, but with qualifiers/conditions (e.g., “without the West Asia impact”, “too hard to put a number” on margin improvement timing).
2. Key Themes from Management Commentary
- Execution / capacity build-out
- Hydra manufacturing: 2 double-wall lines commercial production from 30 Jun 2026; 3rd line expected in Q2 FY27.
- Glassware capex pipeline: Bharuch dedicated facility (capex ~INR 42 cr; commission by end Q3 FY27); Jaipur furnace expansion (capex ~INR 50 cr; commission by end Q4 FY28).
- Energy transition / cost resilience
- Third captive solar plant with battery storage commissioned in Q1 FY27; solar meets ~61% of energy requirement.
- Additional solar capacity under evaluation (6.5 MWp at Borosil; 3–4 MWp at Stylenest for Hydra).
- Demand and mix
- Growth led by volume: Glassware and Opalware described as “essentially volume-led” with price realization lagging.
- Hydra category remains a drag due to BIS compliance headwinds.
- Margin pressure drivers
- EBITDA margin down to 14.6% (vs 17.8% prior year), attributed to fuel + packaging inflation from West Asia conflict (~INR 10 cr net impact) partially offset by price hikes.
- Capital allocation / ROCE narrative
- Continued capex despite weak ROCE history; management frames ROCE as a medium-term outcome of ramp-up + scaling + solar savings.
3. Q&A Analysis
Theme A: Price vs volume, margin sustainability (Glassware & Opalware)
- Core questions
- Split growth into price-led vs volume-led for Glassware and Opalware.
- How much price hike was taken in Q1 and when will it reflect?
- Is margin pressure due to input inflation or China dumping?
- What are sustainable margins?
- Management response
- Growth is primarily volume-led; price pass-ons have a lag.
- Price hikes: ranges “5% to 7%… depending on the category”; realization expected from Q2 onwards.
- Margin pressure: West Asia crisis (fuel + packaging) is the main driver; not China dumping as the primary cause in Q1.
- Overall EBITDA margin confidence: “about 18% to 20%… on the overall business” (excluding West Asia impact).
- Evasive/partial answers
- They avoid category-wise margin disclosure (“we don’t share category-wise margins”).
- For “how much price hike realized in Q1,” they give ranges but also emphasize realization lag and “wait and watch.”
Theme B: FY27 guidance (EBITDA margin, capex, depreciation, utilization)
- Core questions
- Confirm FY27 EBITDA margin guidance and whether it includes other income.
- Capex guidance for FY27; depreciation expectation.
- Utilization levels for Glassware and Opalware; revenue growth expectations for the rest of the year.
- Management response
- EBITDA margin guidance: ~18% EBITDA margins for FY27, and excluding other income.
- Capex: INR 125 cr (two glassware projects) with total INR 125–150 cr; includes possible solar/maintenance.
- Depreciation: ~INR 92 cr (including Hydra plant).
- Utilization: Glassware ~90%, Opalware “full capacity utilization”.
- Revenue: expects growth in both segments, but avoids a single numeric growth rate for both.
- Unusually strong / notable
- They maintain confidence in FY27 margin despite Q1 margin decline, but tie it to input normalization and lagged price realization.
Theme C: China dumping / antidumping status (Borosilicate glass)
- Core questions
- Has Chinese dumping reduced due to rupee depreciation and freight changes?
- If status quo persists, what happens to normalized borosilicate glass margins?
- Any contribution from favorable antidumping to FY27 margin guidance?
- Management response
- Dumping continues: “not seeing much of a difference”.
- They do not provide category-wise margin outlook.
- Antidumping investigation: ongoing; FY27 margin guidance does not assume favorable outcome.
- Evasive/partial
- No quantitative margin impact despite the question; repeated reliance on “depends” and “we don’t share category-wise margins.”
Theme D: Solar savings and how they flow to EBITDA
- Core questions
- Incremental solar savings in FY27.
- Whether savings are straight to EBITDA or used for pricing to drive growth.
- Management response
- FY27 solar Phase 3 savings: ~INR 27–28 cr at EBITDA level.
- They will leverage solar for competitiveness and also increasing margins, but net retention vs pass-through is market-dependent (“too hard to comment”).
Theme E: Working capital / inventory dynamics
- Core questions
- Is Q1 growth helped by channel inventory stocking ahead of price hikes?
- Inventory movement from Q4 to Q1; any liquidation?
- Management response
- Rejects “forced sale/inventory stocking” theory: price impact comes in Q2.
- Inventory typically rises into Diwali season; build for new products/portfolio expansion.
Theme F: ROCE credibility and capital allocation rationale
- Core questions
- Why keep investing when ROCE has been weak (~10% for years)?
- Bridge from ~11% ROCE (FY26) to ~22% ROCE; is it depreciation wearing off vs margin improvement?
- Why not guide ROCE?
- Management response
- ROCE is medium-term; capex cycles + ramp-up + inventory build from BIS issues depressed ROCE.
- Target: 20%–24% ROCE margins medium term; also mentions improving margins to ~18% could lift ROCE.
- They provide some mechanism: scaling utilization, fixed cost leverage, solar savings, and inventory reduction over time.
- Evasive/partial
- They do not provide a numeric ROCE bridge; repeatedly state timing is uncertain due to West Asia and input/price lag.
4. Guidance / Outlook
Explicit guidance (quantitative)
- Revenue (Q1 actual): INR 253.6 cr (+9% YoY) — historical actual, not guidance.
- EBITDA margin (FY27): ~18% EBITDA margins (excluding other income).
- Capex (FY27): INR 125–150 cr total
- INR 125 cr for two glassware projects (Bharuch facility + furnace expansion)
- plus potential solar/maintenance.
- Depreciation (FY27): ~INR 92 cr (including Hydra plant).
- Utilization:
- Glassware: ~90%
- Opalware: full capacity utilization (no exact %).
- Solar savings (FY27): INR 27–28 cr at EBITDA level (Phase 3 impact).
Implicit signals (qualitative)
- Price realization lag: Q1 price hikes are expected to reflect from Q2 onwards.
- Margin recovery depends on: normalization of fuel/packaging costs and continued execution; management repeatedly frames confidence as “without West Asia impact”.
- Hydra ramp-up: commercial production already started; management expects better positioning before Diwali stocking.
- No reliance on antidumping relief for FY27 margin.
5. Standout Statements (direct / highly revealing)
- On margin driver and timing
- “The lower margins are primarily attributable to input cost inflation… arising from the West Asia conflict.”
- “price… realization will come in from Q2 onwards” (repeated across categories).
- On price hikes
- “ranges between 5% to 7% depending on the category… not a standard price increase.”
- On dumping
- “we are not seeing much of a difference as far as the Chinese dumping is concerned.”
- On FY27 margin confidence
- “For FY27, yes, it remains… about 18% EBITDA margins.”
- Clarification: “18%… in a steady-state business without the West Asia impact.”
- On solar
- “overall savings… will be about INR 27 crores, INR 28 crores at EBITDA level.”
- On ROCE
- “That number is not an immediate number. It’s a medium term probably where we’re going to reach.”
- Target: “20% to 24% ROCE margins on the business.”
6. Red Flags / Positive Signals
Red flags
– Guidance vs history tension: FY27 EBITDA margin guided at ~18% while Q1 margin is 14.6%, and management admits West Asia impact + lagged price realization.
– Category-wise transparency limits: repeated refusal to share category-wise margins even when asked about borosilicate normalized margins under dumping.
– ROCE bridge not quantified: medium-term ROCE targets given, but no numeric bridge from current ROCE to 22%.
– Dumping persists: despite rupee depreciation and freight changes, dumping impact remains.
Positive signals
– Execution credibility on capex ramp: Hydra lines commissioned; third line expected Q2 FY27; Bharuch facility expected by end Q3 FY27.
– Energy cost mitigation: solar with battery storage and solar meeting ~61% of energy requirement.
– Price pass-through strategy: management claims full cost pass-on, with realization lag—suggests a controllable lever.
– Clear inventory seasonality explanation (Diwali build) and rejection of “forced stocking” narrative.
7. Historical Comparison & Consistency Analysis (vs prior calls)
a. Change in Tone Over Time
- More Cautious vs earlier optimism
- Feb 2026 / May 2026 calls: management was more confident about reaching low-20s EBITDA and “road map” to margin improvement; also framed issues as temporary (Hydra supply, cost normalization).
- Q1 FY27 (Aug 2026): confidence remains, but they emphasize West Asia conflict impact and lagged price realization, and they avoid category-wise margin answers more often.
- Classification: More Cautious (more hedging/conditions around West Asia and “wait and watch”).
b. Tracking Past Commitments vs Outcomes
- Hydra ramp-up / BIS compliance
- Prior narrative (Feb 2026): Hydra ramp-up expected with domestic sourcing; management targeted ROCE 24% for Hydra long-term and said demand was strong.
- Current (Aug 2026): Hydra still a material headwind; BIS compliance impacts sales/margins; only now commercial production from 2 lines and 3rd line expected Q2.
- Status: ⏳ Delayed / still in progress (commercial production only now; margin drag persists).
- Solar savings
- Prior (May 2026): solar Phase 3 savings guided at ~INR 28 cr at EBITDA level for FY27.
- Current (Aug 2026): reiterates INR 27–28 cr at EBITDA level.
- Status: ✅ Consistent / likely on track.
- EBITDA margin trajectory
- Feb 2026: management suggested margins would move to low-20s with hydra supply returning and cost control.
- Aug 2026: FY27 guided 18% (excluding West Asia impact) while Q1 is 14.6%.
- Status: ⏳ Not yet achieved; guidance lowered/conditioned vs earlier “low-20s” framing.
c. Narrative Shifts
- From “Hydra supply is the main issue” → “West Asia conflict is the main near-term margin issue.”
- Earlier calls: Hydra/BIS supply constraints dominated the story.
- Current call: West Asia fuel/packaging inflation is the dominant explanation for margin decline, even as Hydra remains problematic.
- More emphasis on energy regulation compliance
- Solar with battery storage and open access regulations becomes a stronger part of the narrative in Q1 FY27.
d. Consistency & Credibility Signals
- Medium credibility
- Strength: management consistently explains price pass-through lag and ties margin to input normalization.
- Weakness: repeated inability to provide category-wise margin or a quantified ROCE bridge, plus persistent dumping headwind despite prior discussions.
- No clear pattern of outright contradictions, but precision is limited and timing remains uncertain.
e. Evolution of Key Themes
- Demand: still framed as resilient; growth continues, but management stresses volume-led rather than price-led.
- Margins: deterioration in Q1 FY27 attributed to West Asia; earlier calls expected faster margin recovery.
- Expansion: capex pipeline remains active and detailed (Bharuch, furnace expansion, Hydra lines).
- Regulatory: BIS/QCO compliance remains a recurring operational driver; now also includes Green Energy Open Access.
f. Additional Insights (cross-period)
- Inventory as a structural ROCE drag is now explicitly linked to BIS challenges and ramp-up cycles (ROCE weakness explained by inventory build + capex depreciation). This theme is consistent with earlier inventory discussions, but the ROCE target is still not operationalized with a bridge.
- China dumping remains “sticky”: management previously highlighted dumping as a margin irritant; in Aug 2026 they state it persists despite macro tailwinds, suggesting structural pricing pressure may last longer than hoped.
